EIR

Exercise Immunology Review (EIR) Issue 30 is Now Available

Signed in as:

filler@godaddy.com

Account

Exercise Immunology Review (EIR)

An Official Peer-Reviewed Publication of the International Society of Exercise and Immunology (ISEI)

Editorial Statement

Exercise Immunology Review, an official publication of the International Society of Exercise and Immunology and of the German Society of Sports Medicine and Prevention, is committed to developing and enriching knowledge in all aspects of immunology that relate to sport, exercise, and regular physical activity. In recognition of the broad range of disciplines that contribute to the

understanding of immune function, the journal has adopted an interdisciplinary focus. This allows dissemination of research findings from such disciplines as exercise science, medicine, immunology, physiology, behavioral science, endocrinology, pharmacology, and psychology.

Exercise Immunology Review publishes review articles that explore:

(a) fundamental aspects of immune function and regulation during exercise.

(b) interactions of exercise and immunology in the optimization of health and protection against acute infections.

(d) prevention or modulation of the effects of aging or disease (including HIV infection; cancer; autoimmune, metabolic or transplantation associated disorders) through exercise.

(e) instrumental use of exercise or related stress models for basic or applied research in any field of physiology, pathophysiology or medicine with relations to immune function.

Author Instructions

EIR usually solicits papers from authors with acknowledged expertise in the field to be covered. Unsolicited papers will be considered and can also be accepted. All papers are subject to a peer review process. Usually the manuscripts will fit into one of two major categories: I) A review which thoroughly covers the area indicated in the heading and includes structuring and critical discussion of existing knowledge and, if possible, the ideas of the authors about potential practical consequences and future developments. Mere mentioning and listing of existing literature is not considered to be a good review. The review can be long, if necessary, or short, if the field covered by the heading is relatively new or very focused. II) a paper showing original data accompanied by an extended, review-type discussion.

The general format of the review is somewhat flexible. A review must however have an abstract, an introduction and a conclusion around the main sections. Reviews with three or more sections should list the headings of the sections in form of a bullet point table at the end of the introduction. Longer sections should also give a short interim summary at their end. If substantial amounts of the authors‘ own new data are to be shown, a section on methods and on results must be included. Data will only be accepted, if methods are stated clearly and appropriate statistical evaluation of results is given. Other types of papers, eg true meta-analyses of a circumscribed sector of literature or papers focusing on new ideas or hypotheses may also be considered. Interested authors, please contact the editorial board.

For reference style use the one as applied by J. Appl. Physiol., with references listed in alphabetical order. In text use ref. numbers in brackets. When giving more than 1 reference in one bracket, use numerical order. The maximum number of references is normally 150. A short running head should appear after the title, followed by the authors and their respective affiliations. The full address of correspondence should include an e-mail address of the correspondent author. Up to five key words should be added after the abstract. Please use e-mail for all communications including manuscript submission (word or pdf-file) if possible and paste "EIR” in the subject field of your mailing program. Generally, the submission deadline for the next issue of EIR is September, 30th

Exercise Immunology Review (ISSN 1077-5552)

Scopus CiteScore: 13.6 (2021)

Impact Factor: 11.065 (2021)

Editorial Board

Editor-in-Chief*

Karsten Krüger
Justus-Liebig-University, Gießen, Germany

Karsten.Krueger@sport.uni-giessen.de

Associate Editors

Jonathan Peake

Queensland University of Technology, Australia

jonathan.peake@qut.edu.au

Richard J. Simpson

The University of Arizona, USA

rjsimpson@arizona.edu

Neil Walsh

Liverpool John Moores University, UK

N.Walsh@ljmu.ac.uk

Editorial Board

Stéphane Bermon

Monaco Institute of Sports Medicine and Surgery, Monaco

Lindy Castell

University of Oxford, UK

Maree Gleeson

University of Newcastle, Australia

Frank C. Mooren

University of Witten/Herdecke, Germany

David C. Nieman

Appalachian State University, USA

Katsuhiko Suzuki

Waseda University, Japan

Jeffrey A. Woods

University of Illinois Urbana-Champaign, USA

*send editorial correspondence

EIR Archives

EIR Editorial Policies

Editorial Policies

EIR has several editorial policies in place to ensure the quality and accuracy of the information it provides. Some of these policies include:

1. Peer Review: EIR requires that all scientific content undergoes a rigorous peer-review process before it is published. This ensures that the content meets high standards of scientific quality and accuracy.

2. Retraction Policy: EIR has a policy for retracting published articles in cases of scientific misconduct, data fabrication, or other serious issues that affect the validity of the research.

3. Plagiarism Policy: EIR takes plagiarism seriously and has a policy to identify and address any instances of plagiarism in its content.

4. Conflict of Interest Policy: EIR requires authors to disclose any potential conflicts of interest related to their research. This includes financial or other relationships that could affect the interpretation of the research.

5. Copyright Policy: EIR respects copyright laws and requires authors to obtain permission to use copyrighted material in their publications.

Overall, EIR's editorial policies aim to maintain the highest standards of scientific integrity and accuracy, and to ensure that the information provided by the organization is reliable and trustworthy.

Peer review policy

EIR follows a rigorous peer review policy to ensure that the scientific content it publishes meets high standards of quality and accuracy. The peer review process involves the following steps:

1. Submission: Authors submit their manuscript to a journal.

2. Initial Screening: The editor-in-chief or associate editor screens the manuscript to ensure that it meets the scope and quality criteria of the journal or database.

3. Assignment: The editor assigns the manuscript to two or more independent experts in the field for peer review.

4. Review: The peer reviewers assess the manuscript for scientific soundness, methodological rigor, and other criteria relevant to the specific field. They provide feedback to the author(s) and make recommendations to the editor regarding acceptance, revision, or rejection of the manuscript.

5. Decision: Based on the peer reviews and other editorial criteria, the editor makes a decision on whether to accept, reject, or request revisions to the manuscript. The author(s) receive feedback on the decision and recommendations for revisions.

6. Revision: If the manuscript is accepted with revisions, the author(s) revise the manuscript and resubmit it for further review.

7. Final Decision: After the revisions are reviewed and approved, the manuscript is published in the journal or database.

Overall, EIR's peer review policy is designed to ensure that the scientific content it publishes is of high quality and meets the standards of the scientific community.

In accordance with our journal's peer review policy, we conduct a non-anonymous review process. Submissions undergo evaluation by a minimum of two expert reviewers who are carefully selected based on their subject matter expertise. It is our priority to ensure that reviewers have no conflicts of interest with the authors or their work. This approach to peer review aims to maintain the highest standards of impartiality and objectivity in the assessment of submitted manuscripts.

Advertising policy

EIR does not engage in commercial advertising or promotion of any products or services. Therefore, EIR has a strict advertising policy that prohibits any form of advertising on its websites, databases, and publications. This includes ads for pharmaceuticals, medical devices, and other health-related products.

EIR's advertising policy is in place to ensure that the organization maintains its objectivity and integrity as a trusted source of biomedical and genomic information. The organization's primary goal is to provide reliable, accurate, and up-to-date information to researchers, healthcare professionals, and the public without any commercial influence.

However, EIR does provide links to external websites and resources that may contain commercial advertisements. In such cases, EIR does not endorse any of the products or services advertised on those external sites.

Ethics policy

EIR guidelines require that all research involving human subjects must be reviewed and approved by an Institutional Review Board (IRB) before it can be conducted. The IRB is responsible for ensuring that the research meets ethical standards, and that the risks to participants are minimized and reasonable in relation to the potential benefits.

EIR also requires that all authors submitting manuscripts to its journals comply with the ethical standards set forth by the Committee on Publication Ethics (COPE). COPE provides guidelines for ethical behavior in publishing, including guidelines on authorship, plagiarism, data fabrication and falsification, and conflicts of interest.

Overall, EIR and its journals are committed to upholding the highest ethical standards in research and publishing, in order to ensure the integrity and credibility of the scientific enterprise.

Policy for research involving animals

Research involving animals must adhere to specific guidelines. A statement confirming the approval of the research protocol by an Institutional Animal Care and Use Committee (IACUC) or an equivalent body is required in the Methods section of the paper. The manuscript should provide a clear description of the animal procedures, enabling readers to assess the data's quality and replicate the experiments if necessary. In cases involving surgeries or other painful procedures, authors must explain the measures taken to alleviate pain and distress, detailing the types and dosages of anesthetics and post-operative analgesics used. It is important to note that curarizing agents are not considered anesthetics. If they were used, the manuscript must provide evidence of the use of appropriate-grade anesthesia for the necessary duration. Authors are encouraged to consult guidelines such as those provided by the Institute for Laboratory Animal Research (National Academy of Sciences), "Guidance for the Description of Animal Research in Scientific Publications," and the National Centre for the Replacement, Refinement, and Reduction of Animals in Research, "Animals in Research: In Vivo Experiments," for additional guidance to determine the relevant elements for their study.

Informed consent policy

Informed consent is an essential aspect of any research project involving human subjects. It is a process by which participants are given information about the research project, including its purpose, procedures, potential risks and benefits, and their rights and responsibilities as participants. Participants are then given the opportunity to ask questions and make an informed decision about whether or not to participate.

Here are the key elements of EIRs informed consent policy:

1. Requirements for informed consent: An informed consent is required, including the need for written consent and the consent process be conducted in a language and manner that is understandable to the participant.

3. Protection of privacy: The policy should emphasize the importance of protecting the privacy of participants and ensuring that their personal information is kept confidential.

4. Special populations: The policy should address the special needs of vulnerable populations, such as children, prisoners, and individuals with cognitive or mental disabilities, and outline additional safeguards that may be necessary to ensure that they are able to provide informed consent.

5. Institutional Review Board (IRB) approval: The policy should require that all research involving human subjects receive approval from an IRB or other ethics committee before it is published in the journal.

6. Compliance with ethical guidelines: The policy should require that all research involving human subjects be conducted in compliance with established ethical guidelines, such as the Declaration of Helsinki, the Belmont Report, and the International Conference on Harmonisation (ICH) Guidelines for Good Clinical Practice.

7. Reporting of non-compliance: The policy should require that any instances of non-compliance with the informed consent policy or ethical guidelines be reported to the editor-in-chief of the journal and to the appropriate institutional officials.

By implementing a robust informed consent policy, journals can ensure that research involving human subjects is conducted ethically and with the full knowledge and understanding of the participants, and can help to protect the rights and welfare of human subjects.

Open Access Statement

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.